[New Publication] Self-Boosting Nanoparticles to Enhance Cancer Therapy

Thrilled to share our latest work in collaboration with Shenyang Pharmaceutical University, now published in the International Journal of Pharmaceutics:

Title:
Self-amplifying ROS-responsive trinity nanodelivery system for enhanced cancer therapy

Highlights:

• Ferroptosis, a newly emerging cell death mechanism, holds promise for cancer therapy but faces challenges like off-target toxicity and poor tumor specificity.
• We developed a ROS-responsive trinity nanodelivery system that combines:
  🔸 Iron overload (ROS burst via Fenton reaction)
  🔸 Antioxidant inhibition (GPX4 blockade by RSL3)
  🔸 Substrate supply (arachidonic acid for lipid peroxidation)
• This cascade amplification approach induces robust ferroptosis, as demonstrated in tumor-on-a-chip platforms and in vivo studies.
• Our findings lay a solid foundation for the development of precise ferroptosis-targeted nanomedicines.

🧪 This study showcases the power of integrating nanotechnology with advanced in vitro and in vivo models to address ferroptosis resistance and enhance cancer treatment strategies.

👉 Read the full article here: https://doi.org/10.1016/j.ijpharm.2025.126091

Congratulations to all collaborators and team members for this achievement!

#CancerTherapy #Ferroptosis #Nanomedicine #DrugDelivery #TumorOnAChip #Collaboration #ResearchInnovation